Research & Development: Page 57
-
PharmaVoice Team/PharmaVoice
Last Word
Bridging Science and Patients Dr. Victoria Richon, VP of discovery and preclinical research oncology at Sanofi Oncology, discusses how translational medicine efforts are moving the company forward. Sidebar: Sanofi’s Commitment to Translational Medicine The Last Word PV: How do you define translat...
By PharmaVoice Team • Aug. 23, 2013 -
PharmaVoice Team/PharmaVoice
Talent Pool
Emerging POOL Dr. Deborah DUNSIRE EnVivo Pharmaceuticals Appoints President and CEO EnVivo Pharmaceuticals, a privately held company working to convert its broad pipeline into a range of CNS therapies that leverage novel mechanisms of action by altering the progression of disease and providing im...
By Ann Grey • Aug. 23, 2013 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: Accenture Launches Accelerated R&D Services Parexel Launches New Functional Services Unit Hudson and QuantiaMD Partner to Provide Personalized Service to Physicians TransCelerate BioPharma Unveils Collaborative Methodol...
By Ann Grey • Aug. 23, 2013 -
PharmaVoice Team/PharmaVoice
UpFront
INDUSTRY at Large Raising Awareness About MS Medicare Patients are Satisfied with Pharmacy Choices Side Effects Limit Prescription Drug Compliance Understanding Gout New Drug Approvals to Treat Neglected Diseases Double Healthcare Spending to Slow Awards… Ariad CEO Awarded by EY Catalent Wins Two...
By Denise Myshko • Aug. 22, 2013 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Behavior Change — Easier Said Than Done Lose 10 pounds, eat healthier, exercise more, reduce stress, take our medication as directed, Etc. Knowing what to do is the easy part. Doing what we are supposed to do is a whole lot harder. Let’s face it, it’s much easier to be noncompliant, and the healt...
By Taren Grom • Aug. 22, 2013 -
PharmaVoice Team/PharmaVoice
Giving Back Through Mentoring
Giving Back Through Mentoring By Robin Robinson The PharmaVOICE 100 honorees talk about why being a mentor is important in today’s business environment. Many of our PharmaVOICE 100 honorees credit their mentors for helping them succeed in their own careers, and they participate either in formal o...
By Taren Grom • July 30, 2013 -
PharmaVoice Team/PharmaVoice
Hidden Talents
Hidden Talents What are their hidden talents? Our honorees have and share a multitude of talents. They are creative, innovative, encouraging, visionary, engaging, etc. But they also have some lesser known abilities that make them uniquely them. Dr. Dan Baker throws a mean curveball. Dr. Scott C...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Reading List
Reading List What are they reading? The PharmaVOICE 100 are constant learners and are tapping into new and time-tested books on a variety subjects, of particular note business and leadership topics. We’ve included a selection of what’s hot on their reading list. The Lean Start Up is on the read...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Cloak of Invisibility
If they were invisible, where would they go? While several of our honorees indicated they like to be present at all times, many of our PV 100 honorees wouldn’t mind donning a cloak of invisibility in some unusual places. Andrew Burns would like to have been in the locker room to hear Herb Brooks...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Favorite APPs
Favorite APPs Social Media Mavens Follow and connect with the PV 100 via Twitter, LinkedIn, and Facebook to find out what they have to say about the state of healthcare. And check out the apps that keep them organized and entertained. Favorite APPLICATIONS Uber Request a private car in any city t...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Giving Back
The PharmaVOICE 100 honorees share a sincere desire to give back. Their philanthropic endeavors range from participation in company-based service days to providing resources and assistance to their communities, schools, and national and global organizations. Favorite charities American Cancer Soc...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Alternate Professions
What profession, other than theirs, would the PharmaVOICE 100 like to attempt? Not surprising, several of the honorees identified teaching as their alternate profession of choice, while others have an affinity for blogging, building, and blending art and science. Dr. Sharon Presnell would work i...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
First Jobs
First Jobs What was their first job? We thought it would be fun to know how these highly successful executives earned their first paychecks. As it turns out, many of them got their start in business by mowing lawns, delivering papers, or working in food service. Christine Pierre ran a babysitt...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Place of Birth
Place of Birth Where they were born? Christine Pierre and Steve Collis were born 10,532 miles (16,945.99 kilometers) apart, but they share a global perspective on improving healthcare. Dr. Dominic Behan, Tim Davis, Jamie Heywood, Joanne Kamens, Dr. Daniel Kraft, Andrea McGonigle, Mike Rea have t...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
The Clinical Specialists
The Clinical Specialists Kent Thoelke Making a Difference Around the World Driven. Thoughtful. During his career in clinical research, Kent Thoelke has established an inspiring, industry-wide reputation for moving the current clinical drug development paradigm toward a more evidence-based strat...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
The Commanders & Chiefs
David Hahn On the Money with Knowledge and Foresight In a hyper-competitive business climate, success requires constant innovation. For David Hahn, this means constantly improving to meet clients’ expectations. Mr. Hahn has been an integral part of the success of The Medical Affairs Company (TMAC...
By PharmaVoice Team • July 29, 2013 -
PharmaVoice Team/PharmaVoice
PharmaVOICE 100 - Who's on the List by Section
The Commanders & Chiefs David Berry Pronutria Damian Braga Sanofi Pasteur David Bruggeman Clinical Research Advantage Walter Capone The Multiple Myeloma Research Foundation Steve Collis AmerisourceBergen Corp. Nick Colucci Publicis Healthcare Communications Group Jim Curtis Remedy Health Medi...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Talent Pool
Talent Pool By Ann Grey Pharma Pool Dave Lemus Sigma-Tau Pharmaceuticals Names CEO Sigma-Tau Pharmaceuticals Inc. has promoted Dave Lemus to the newly created position of CEO. Mr. Lemus had served as chief operating officer of the company since March 2012 and he joined the company as VP of financ...
By Ann Grey • July 29, 2013 -
PharmaVoice Team/PharmaVoice
On the Calendar
August 5, Medicare Chronic Care Pre-Conference Workshop Hyatt Regency Orange County, Garden Grove, Calif. Opal Events, http://www.opalevents.org/p/92/medicare-chronic-care-pre-conference-workshop August 5-7 Active Pharmaceutical Ingredient (API) and Drug Product Specifications The Hilton Los Ange...
By PharmaVoice Team • July 29, 2013 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Trending Now: Payer approaches to specialty drugs reveal innovation and experimentation as payers navigate this dynamic healthcare marketplace. Ensuring the appropriate use of specialty drugs is a major priority for health plans today and will become increasingly important for their future growth...
By Denise Myshko • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Sunshine Act Compliance MMIS Launches Spend Solution for Smaller Companies E-UPGRADES Veeva Systems Introduces Customer Master Solution Tools of the Trade Trending Now: Software-as-a-service solution provides cus...
By Denise Myshko • July 29, 2013 -
PharmaVoice Team/PharmaVoice
2013 PharmaVOICE 100 - Who's on the List by Company
2013 PharmaVOICE 100 – Who’s on the List by Company Indexed by Company Affiliation Accelrys Ken Rapp Acorda Therapeutics Denise Duca Acurian Kristin Gross Addgene Dr. Joanne Kamens Advanced Clinical Concepts David Rear Agano Solutions and Auditgraph Mauricha Marcussen AmerisourceBergen Corp. Stev...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Letter from the Editor By Taren Grom The 2013 PharmaVOICE 100 Each year we have the privilege of showcasing 100 of the most inspiring and motivational individuals throughout the life-sciences industry. This special issue, now in its ninth year, once again showcases the individuals as identified b...
By Taren Grom • July 29, 2013 -
PharmaVoice Team/PharmaVoice
Take the Express Toward NDA Approval
Pharmaceutical manufacturers spend on average $1 billion developing a product for commercialization. With this tremendous investment, it is a pharmaceutical developer’s nightmare to have its product fail during the New Drug Application (NDA) filing process due to safety concerns or lack of pharma...
By Michael O'Gorman • May 29, 2013 -
PharmaVoice Team/PharmaVoice
Defining Innovation Differently
Innovation, it seems, is the buzzword in every business strategy plan. It’s what pharmaceutical training has always taught us to aspire to. We all want to stay ahead of the curve. And yet, like most of the words in the dictionary, how many ideas are truly new? How many are truly innovative? Well,...
By Mark A. Lanfear • May 29, 2013
Previous
